Girish Mahajan (Editor)

5 MeO MPMI

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
CAS Number  143321-57-7
ChemSpider  8057000
Formula  C15H20N2O
Molar mass  244.332 g/mol
PubChem CID  9881324
ChEMBL  CHEMBL137485
3D model (Jmol)  Interactive image
5-MeO-MPMI

5-MeO-MPMI (also known as 5-Methoxy-N-methyl-(α,N-trimethylene)tryptamine) is a tryptamine derivative that is a psychedelic drug. It was first developed by the team led by JE Macor in 1992, and subsequently investigated by the team led by David Nichols from Purdue University in the late 1990s. This compound produces psychedelic-appropriate responding in animal tests with a similar potency to the amphetamine-derived psychedelic DOI, and has two enantiomers, with only the (R)-enantiomer being active.

References

5-MeO-MPMI Wikipedia


Similar Topics
Family Plan
Fatima Baquiran
Avi Nimni
Topics
 
B
i
Link
H2
L